[Analysis of our recent results in the surgical treatment of the hyperparathyroidism (1990-2005)].
OBJECTIVE
To report our recent experience (1990-2005) in the surgical treatment of hyperparathyroidism.


METHODS
Up to now we have operated 153 patients (41 male and 112 female) with ages between 14 and 79 years old studying the clinical symptoms referred by them, preoperative imaging tests, type of hyperparathyroidism, its respective surgery, result or final anatomopathological diagnosis and postoperative complications.


RESULTS
Parathyroid adenomas represented a 69.73% while the hyperplasias were about 26.31%. In 6 cases the glands removed were informed as normal. It stands out that the most rare adenomas were located in lower parathyroids with a relation > 5,5:1 respect to the upper ones. Among the complications we obtained 35 postoperative hypocalcemias (31 transient and 4 persistent), one case of recurrent nerve palsy after exposure of 233 nerves, 5 haemorrhages that required reintervention and 4 persistences of hypercalcemia. Globally we were able to reduce the calcium and PTH serum levels with clinical improvement in more than 96% of the operated patients.


CONCLUSIONS
The surgery for hyperparathyroidism provides very good results in general as we stated in other published series.
Pino Rivero
V
V
Servicio de Otorrinolaringología, Complejo Hospitalario Infanta Cristina, Badajoz. vicentepinorivero@terra.com
González Palomino
A
A
Pantoja Hernández
C G
CG
Pardo Romero
G
G
Mora Santos
M E
ME
Barrantes Celaya
G
G
Blasco Huelva
A
A
D000236:Adenoma / Q000473:pathology / Q000601:surgery; D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism / Q000473:pathology / Q000601:surgery*; D006965:Hyperplasia / Q000473:pathology / Q000601:surgery; D006996:Hypocalcemia / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D010282:Parathyroid Neoplasms / Q000473:pathology / Q000601:surgery; D011183:Postoperative Complications / Q000453:epidemiology; D012189:Retrospective Studies; D016896:Treatment Outcome